The PE Ratio as of November 2024 (TTM) for Rocket Pharmaceuticals, Inc. (RCKT) is -5.17

According to Rocket Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.17. This represents a change of -41.35% compared to the average of -8.82 of the last 4 quarters.

Rocket Pharmaceuticals, Inc. (RCKT) Historical PE Ratio (quarterly & annually)

How has RCKT PE Ratio performed in the past?

The mean historical PE Ratio of Rocket Pharmaceuticals, Inc. over the last ten years is -8.43. The current -5.17 PE Ratio has changed 6.04% with respect to the historical average. Over the past ten years (40 quarters), RCKT's PE Ratio was at its highest in in the September 2015 quarter at -0.95. The PE Ratio was at its lowest in in the June 2021 quarter at -20.22.

Rocket Pharmaceuticals, Inc. (RCKT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Rocket Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rocket Pharmaceuticals, Inc. (RCKT) Average PE Ratio

How has RCKT PE Ratio performed in the past?

The current PE Ratio of Rocket Pharmaceuticals, Inc. (RCKT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Rocket Pharmaceuticals, Inc. (RCKT) PE Ratio vs. Peers

How is RCKT’s PE Ratio compared to its peers?

Rocket Pharmaceuticals, Inc.’s PE Ratio is less than uniQure N.V. (-1.18), greater than Rhythm Pharmaceuticals, Inc. (-14.10), less than Solid Biosciences Inc. (-2.16), less than MeiraGTx Holdings plc (-4.82), greater than Vaxcyte, Inc. (-21.57), greater than Larimar Therapeutics, Inc. (-6.07), less than Syndax Pharmaceuticals, Inc. (-4.63), greater than Merus N.V. (-12.70), less than Sutro Biopharma, Inc. (-1.66), greater than Stoke Therapeutics, Inc. (-6.11), less than Pliant Therapeutics, Inc. (-3.91), greater than Dyne Therapeutics, Inc. (-10.17), greater than Cytokinetics, Incorporated (-10.02), greater than Revolution Medicines, Inc. (-16.70), less than REGENXBIO Inc. (-2.04), greater than Day One Biopharmaceuticals, Inc. (-15.73), greater than Replimune Group, Inc. (-5.51), greater than Mirum Pharmaceuticals, Inc. (-21.97), greater than Viridian Therapeutics, Inc. (-5.22), less than Inozyme Pharma, Inc. (-1.84),

Build a custom stock screener for Rocket Pharmaceuticals, Inc. (RCKT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rocket Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rocket Pharmaceuticals, Inc. (RCKT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rocket Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.